<DOC>
	<DOCNO>NCT01052506</DOCNO>
	<brief_summary>The primary objective study evaluate safety tolerability single dose BIIB033 administer healthy adult volunteer .</brief_summary>
	<brief_title>BIIB033 Single Ascending Dose Study Healthy Volunteer Subjects</brief_title>
	<detailed_description>BIIB033 investigational product develop promote remyelination subject multiple sclerosis ( MS ) . This healthy volunteer study evaluate safety tolerability single dose BIIB033 .</detailed_description>
	<criteria>Must good health BMI 1830kg/m2 Contraception require least 6 month study drug administration History clinically significant disease lab value Females childbearing potential Contraindication brain MRI and/or lumbar puncture Treatment prescription medication within 28 day prior study entry Treatment overthecounter product , include herbal and/or alternative health preparation procedure within 14 day prior study entry Regular use tobacco product within 3 month prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Human volunteer</keyword>
</DOC>